Home>Topics>Stocks>Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings

  1. All
  2. Commentary
  3. Fund Reports
  4. Headlines
  1. Laboratory Corp. of America Holdings - Shareholder/Analyst Call

    Headlines

    Wed, 8 May 2013

    Laboratory Corporation of America Holdings ( LH ) May 08, 2013 9:00 ..... Chairman of the Board of Laboratory Corporation of America Holdings and Chairman of the Annual ..... article/1415991- laboratory -corp-of-america

  2. Laboratory of America Holdings Management Discusses Q1 2013 Results - Earnings Call Transcript

    Headlines

    Fri, 19 Apr 2013

    Laboratory of America Holdings ( LH ) Q1 2013 Earnings Call April 19, 2013 9:00 am ET Executives ..... href='http://seekingalpha.com/article/1355051- laboratory -of-america-holdings-management-discusses-q1-2013

  3. Laboratory Corporation LH Q1 2013 Earnings Call Transcript

    Headlines

    Fri, 19 Apr 2013

    Good day, ladies and gentlemen and welcome to the First Quarter 2013 Laboratory Corporation of America Holdings Earnings Conference Call. My name is Janeda and I will be your operator for today. At this time all participants are in a listen

  4. LabCorp ([[ LH ]] +0.3%) says that its subsidiary LabCorp Clinical Trials has been selected as a preferred provider for full-service global central laboratory services and biomarker testing by ...

    Headlines

    Mon, 1 Apr 2013

    LabCorp ( LH +0.3% ) says that its subsidiary LabCorp Clinical Trials ..... selected as a preferred provider for full-service global central laboratory services and biomarker testing by Bristol-Myers Squibb ( BMY -0.2% ). Under the terms of the five-year agreement, LH 's global central lab, biomarker and specialty testing capabilities

  5. Laboratory Corp. of America Holdings Presents at Barclays Global Healthcare Conference, Mar-12-2013 11:15 AM

    Headlines

    Tue, 12 Mar 2013

    Laboratory Corporation of America Holdings ( LH ) March 12, 2013 11:15 am ET Executives David P. King ..... http://seekingalpha.com/article/1266511- laboratory -corp-of-america-holdings-presents-at-barclays

  6. Quest Diagnostics Tests Positive For Value, Negative For Growth

    Headlines

    Tue, 26 Feb 2013

    By Steve Alexander : Quest Diagnostics ( DGX ) is the largest independent clinical testing laboratory firm in the U.S., operating 2,000 service locations nationwide. About 65% of sales are generated through routine ..... don't frequently put off necessary medical testing during a recession. Also, Quest operates a duopoly with LabCorp ( LH ) in the independent lab market, giving it significant doctor recognition and pricing advantages over would-be smaller competitors

  7. Laboratory of America Holdings Management Discusses Q4 2012 Results - Earnings Call Transcript

    Headlines

    Fri, 8 Feb 2013

    Laboratory of America Holdings ( LH ) Q4 2012 Earnings Call February 08, 2013 9:00 am ET Executives ..... href='http://seekingalpha.com/article/1168281- laboratory -of-america-holdings-management-discusses-q4-2012

  8. LabCorp Meets Fourth-Quarter Expectations and Ramps Up Investment for 2013

    Commentary

    Fri, 8 Feb 2013

    LabCorp LH released fourth-quarter and full-year results that generally met our expectations, and we are leaving our $98 fair ..... reimbursement reductions in order to earn economic profits. The firm has just rolled out its new Propel robotic system in its key laboratory in Burlington, N.C. This automation should replace work that is currently done by hand, thereby increasing efficiency

  9. Laboratory Corporation LH Q4 2012 Earnings Call Transcript

    Headlines

    Fri, 8 Feb 2013

    Good day ladies and gentlemen, and welcome to the Quarter Four 2012 Laboratory Corporation of America Holdings Earnings Conference Call. My name is Shawn and I will be your operator today. At this time all participants are in a listen

  10. Verastem ([[VSTM]] -0.2%) signs an agreement with Laboratory Corporation of America ([[ LH ]] +0.4%) to validate biomarkers for its lead focal adhesion kinase inhibitor VS-6063 in the development of an ...

    Headlines

    Wed, 9 Jan 2013

    Verastem ( VSTM -0.2% ) signs an agreement with Laboratory Corporation of America ( LH +0.4% ) to validate biomarkers for its lead focal adhesion kinase inhibitor VS-6063 in the development of an applicable companion

« Prev12345Next »
Content Partners